TNF Pharmaceuticals, Financials
| TNFA Stock | 1.36 0.11 7.48% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | 1.166 |
|
|
The essential information of the day-to-day investment outlook for TNF Pharmaceuticals, includes many different criteria found on its balance sheet. An individual investor should monitor TNF Pharmaceuticals,'s cash flow, debt, and profitability to accurately make informed decisions on whether to invest in TNF Pharmaceuticals,.
Net Income |
|
TNF | Select Account or Indicator |
Please note, the presentation of TNF Pharmaceuticals,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TNF Pharmaceuticals,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TNF Pharmaceuticals,'s management manipulating its earnings.
TNF Pharmaceuticals, Stock Summary
TNF Pharmaceuticals, competes with Oric Pharmaceuticals, Lyra Therapeutics, Inhibrx, ESSA Pharma, and Sensei Biotherapeutics. TNF Pharmaceuticals, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 62856X102 00973E102 00973E409 62856X201 00973E300 |
| Older Symbol | MYMD |
| Location | New York; U.S.A |
| Business Address | 855 N Wolfe |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | tnfpharma.com |
| Phone | 856 848 8698 |
TNF Pharmaceuticals, Key Financial Ratios
| Return On Equity | -2.98 | ||||
| EBITDA | (4 M) | ||||
| Net Income | (4 M) | ||||
| Book Value Per Share | (0.02) X | ||||
| Market Capitalization | 3.13 M |
TNF Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TNF Pharmaceuticals,'s current stock value. Our valuation model uses many indicators to compare TNF Pharmaceuticals, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TNF Pharmaceuticals, competition to find correlations between indicators driving TNF Pharmaceuticals,'s intrinsic value. More Info.TNF Pharmaceuticals, is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, TNF Pharmaceuticals,'s Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TNF Pharmaceuticals,'s earnings, one of the primary drivers of an investment's value.TNF Pharmaceuticals, Systematic Risk
TNF Pharmaceuticals,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. TNF Pharmaceuticals, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on TNF Pharmaceuticals, correlated with the market. If Beta is less than 0 TNF Pharmaceuticals, generally moves in the opposite direction as compared to the market. If TNF Pharmaceuticals, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one TNF Pharmaceuticals, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of TNF Pharmaceuticals, is generally in the same direction as the market. If Beta > 1 TNF Pharmaceuticals, moves generally in the same direction as, but more than the movement of the benchmark.
About TNF Pharmaceuticals, Financials
What exactly are TNF Pharmaceuticals, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include TNF Pharmaceuticals,'s income statement, its balance sheet, and the statement of cash flows. Potential TNF Pharmaceuticals, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although TNF Pharmaceuticals, investors may use each financial statement separately, they are all related. The changes in TNF Pharmaceuticals,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on TNF Pharmaceuticals,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in TNF Pharmaceuticals, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various TNF Pharmaceuticals,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of TNF Pharmaceuticals, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
TNF Pharmaceuticals, December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of TNF Pharmaceuticals, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TNF Pharmaceuticals,. We use our internally-developed statistical techniques to arrive at the intrinsic value of TNF Pharmaceuticals, based on widely used predictive technical indicators. In general, we focus on analyzing TNF Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TNF Pharmaceuticals,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 7.41 | |||
| Information Ratio | 0.0483 | |||
| Maximum Drawdown | 41.7 | |||
| Value At Risk | (13.07) | |||
| Potential Upside | 13.71 |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |